IDO Activity May Be a Potential Early Marker of Graft Rejection in Heart Transplantation
Journal of Heart and Lung Transplantation(2012)
摘要
Indoleamine 2.3-Dioxygenase (IDO) is an inducible enzyme present intracellularly in several cell types including monocytes, macrophages and dendritic cells with an immunosupressive effect on the lymphocyte population. In kidney transplantation IDO has been proposed as a marker of graft rejection, but its role in heart transplantation (HT) is uncertain.
更多查看译文
关键词
graft rejection,ido activity,heart
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要